pentamidine has been researched along with Chronic Disease in 4 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the effect of chronic Pneumocystis carinii pneumonia (PCP) prophylaxis, with a once a month dose of 300 mg of inhalatory pentamidine isethionate, on QT interval duration." | 1.30 | Inhalatory pentamidine therapy and the duration of the QT interval in HIV-infected patients. ( Cardoso, JS; Conde, C; Lecour, H; Mota-Miranda, A; Moura, B; Rocha-Gonçalves, F, 1997) |
| "Chronic mucocutaneous candidiasis is a relatively uncommon form of candida infection, and can be found in patients with primary deficiencies of their immune systems." | 1.26 | An evolution of therapy for mucocutaneous candidiasis. ( Kornblut, AD, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kornblut, AD | 1 |
| Izquierdo Patrón, M | 1 |
| Lafuente, C | 1 |
| Haro Estarriol, M | 1 |
| Arévalo González, M | 1 |
| Cardoso, JS | 1 |
| Mota-Miranda, A | 1 |
| Conde, C | 1 |
| Moura, B | 1 |
| Rocha-Gonçalves, F | 1 |
| Lecour, H | 1 |
| Gray, JS | 1 |
| Pudney, M | 1 |
1 review available for pentamidine and Chronic Disease
| Article | Year |
|---|---|
[Sinus bradycardia secondary to systemic pentamidine].
Topics: Bradycardia; Chronic Disease; Female; HIV Seronegativity; Humans; Injections, Intravenous; Lupus Ery | 1996 |
3 other studies available for pentamidine and Chronic Disease
| Article | Year |
|---|---|
An evolution of therapy for mucocutaneous candidiasis.
Topics: Amphotericin B; Antifungal Agents; Benzalkonium Compounds; Candida; Candidiasis; Candidiasis, Cutane | 1980 |
Inhalatory pentamidine therapy and the duration of the QT interval in HIV-infected patients.
Topics: Administration, Inhalation; Adult; Antibiotic Prophylaxis; Antifungal Agents; CD4 Lymphocyte Count; | 1997 |
Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Atovaquone; Babesiosis; Chronic Disease; Clindamycin; | 1999 |